MOGN
Mgi Pharma Inc
Biopharmaceutical company focused on oncology and acute care therapeutics, commercializing products including Aloxi, Dacogen and Gliadel
CUSIP: 552880106HealthcareUS1 holder
Mgi Pharma Inc
Biopharmaceutical company focused on oncology and acute care therapeutics, commercializing products including Aloxi, Dacogen and Gliadel
No insider transactions reported in the last 5 years. Look across all recorded history →